Patent ID: 9663537
Date: 2017-05-30
CPC Classifications: A61P,C07D

Claim:
1. A method for treating a disease associated with aberrant leukocyte recruitment, aberrant leukocyte activation or aberrant leukocyte recruitment and activation, comprising administering to a subject in need thereof an effective amount of a compound having the formula: or a physiologically acceptable salt thereof, wherein: n is one to four; M is >CR R R R R Z is X Ring A is unsubstituted; R wherein the disease is selected from the group consisting of arthritis, atherosclerosis, arteriosclerosis, restenosis, ischemia/reperfusion injury, diabetes mellitus, psoriasis, multiple sclerosis, inflammatory bowel diseases, resection of a transplanted organ or tissue, graft versus host disease, allergy and asthma.